Syneos Health Investor Relations Material
Latest events
Q4 2022
Syneos Health
Q2 2023
9 Aug, 2023
Q1 2023
10 May, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Syneos Health Inc
Access all reports
Syneos Health Inc is a contract research and commercialization organization serving the biopharmaceutical industry. The company provides clinical development, regulatory consulting, and commercialization solutions from early-phase trials through post-approval support. It partners with clients globally to bring therapies to market. The company is headquartered in Morrisville, North Carolina, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SYNH
Country
🇺🇸 United States